PER - total fail in results and trial being discontinued. Bad for shareholders I'll be surprised if this doesn't get smashed by an 80% drop. Even worse for patients who really have no hope and the glimmer offered by PER ended up being a mirage.
ASX Market Close: Local bourse manages last gasp of green cheer heading into Chrissy shutdown | Dec 24, 2024
Almonty's Black on tungsten's global market and why 'not making a big hububaloo' about supply is so key
STX Strike Energy was HotCopper's Most Watched stock in 2024 - and it's still a 'fantastic opportunity'
